[go: up one dir, main page]

WO2002002610A3 - Molecules de circulation et de secretion - Google Patents

Molecules de circulation et de secretion Download PDF

Info

Publication number
WO2002002610A3
WO2002002610A3 PCT/US2001/020704 US0120704W WO0202610A3 WO 2002002610 A3 WO2002002610 A3 WO 2002002610A3 US 0120704 W US0120704 W US 0120704W WO 0202610 A3 WO0202610 A3 WO 0202610A3
Authority
WO
WIPO (PCT)
Prior art keywords
sat
secretion
trafficking molecules
provides
trafficking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/020704
Other languages
English (en)
Other versions
WO2002002610A2 (fr
Inventor
Ernestine A Lee
Yan Lu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to JP2002507862A priority Critical patent/JP2004528002A/ja
Priority to EP01952303A priority patent/EP1294884A2/fr
Priority to CA002410679A priority patent/CA2410679A1/fr
Priority to AU2001273070A priority patent/AU2001273070A1/en
Publication of WO2002002610A2 publication Critical patent/WO2002002610A2/fr
Publication of WO2002002610A3 publication Critical patent/WO2002002610A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne des molécules de circulation et de sécrétion humaines (SAT) et des polynucléotides qui identifient et codent ces SAT. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Enfin, l'invention concerne des procédés de diagnostic, de traitement et de prévention de troubles associés à l'expression anormale des SAT.
PCT/US2001/020704 2000-06-29 2001-06-28 Molecules de circulation et de secretion Ceased WO2002002610A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002507862A JP2004528002A (ja) 2000-06-29 2001-06-28 分泌分子および輸送分子
EP01952303A EP1294884A2 (fr) 2000-06-29 2001-06-28 Molecules de secretion et de transport
CA002410679A CA2410679A1 (fr) 2000-06-29 2001-06-28 Molecules de circulation et de secretion
AU2001273070A AU2001273070A1 (en) 2000-06-29 2001-06-28 Secretion and trafficking molecules

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21546500P 2000-06-29 2000-06-29
US60/215,465 2000-06-29
US23938400P 2000-10-10 2000-10-10
US60/239,384 2000-10-10
US25363900P 2000-11-28 2000-11-28
US60/253,639 2000-11-28

Publications (2)

Publication Number Publication Date
WO2002002610A2 WO2002002610A2 (fr) 2002-01-10
WO2002002610A3 true WO2002002610A3 (fr) 2002-09-19

Family

ID=27396128

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/020704 Ceased WO2002002610A2 (fr) 2000-06-29 2001-06-28 Molecules de circulation et de secretion

Country Status (5)

Country Link
EP (1) EP1294884A2 (fr)
JP (1) JP2004528002A (fr)
AU (1) AU2001273070A1 (fr)
CA (1) CA2410679A1 (fr)
WO (1) WO2002002610A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002234595A1 (en) * 2000-12-30 2002-07-16 Lion Bioscience Ag Mammalian nuclear receptor cofactor cf11 and methods of use
WO2002053591A1 (fr) * 2000-12-30 2002-07-11 Lion Bioscience Ag Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
WO2003093466A1 (fr) * 2002-05-02 2003-11-13 Bayer Healthcare Ag Proteine humaine associee au rhomboide
WO2005090569A1 (fr) * 2004-03-24 2005-09-29 The Council Of The Queensland Institute Of Medical Research Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
EP2320931A4 (fr) * 2008-07-18 2013-03-27 Univ New Jersey Med Compositions comprenant des acides nucléiques mg29, polypeptides et procédés associés d utilisation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025699A1 (fr) * 1992-06-11 1993-12-23 The Regents Of The University Of California Proteines de transport a travers la membrane de vesicules
WO1998037094A2 (fr) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
WO1999016875A1 (fr) * 1997-09-30 1999-04-08 Yale University Procede servant a effectuer le controle selectif de la presence d'une proteine de membrane et de la secretion de proteines dans des cellules eucaryotes
WO2000012703A2 (fr) * 1998-08-27 2000-03-09 Incyte Pharmaceuticals, Inc. Molecules associees au transport de proteines
EP1033401A2 (fr) * 1999-02-26 2000-09-06 Genset Marqueurs de séquence exprimées et protéines humaines codées
WO2000056767A1 (fr) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. Proteines humaines secretees (46)

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993025699A1 (fr) * 1992-06-11 1993-12-23 The Regents Of The University Of California Proteines de transport a travers la membrane de vesicules
WO1998037094A2 (fr) * 1997-02-24 1998-08-27 Genetics Institute, Inc. Proteines secretees et polynucleotides les codant
WO1999016875A1 (fr) * 1997-09-30 1999-04-08 Yale University Procede servant a effectuer le controle selectif de la presence d'une proteine de membrane et de la secretion de proteines dans des cellules eucaryotes
WO2000012703A2 (fr) * 1998-08-27 2000-03-09 Incyte Pharmaceuticals, Inc. Molecules associees au transport de proteines
EP1033401A2 (fr) * 1999-02-26 2000-09-06 Genset Marqueurs de séquence exprimées et protéines humaines codées
WO2000056767A1 (fr) * 1999-03-19 2000-09-28 Human Genome Sciences, Inc. Proteines humaines secretees (46)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 18 June 2000 (2000-06-18), R.H. WATERSTON: "Homo sapiens chromosome 2 xlone RP11-803F15", XP002193349 *
DATABASE EMBL SEQUENCE DATABASE Hinxton, UK; 23 September 1999 (1999-09-23), J.E. SULSTON AND R. WATERSON: "Homo sapiens BAC clone RP11-395N3 from 2, complete sequence", XP002193417 *
DATABASE GENSEQ DATABASE NCBI, US; 6 October 2000 (2000-10-06), GENSET: "Human secreted proteins 5' EST , SEQ ID No: 23886", XP002193416 *
DATABASE GENSEQ SEQUENCE DATABASE Hinxton, UK; 2 February 2001 (2001-02-02), HUMAN GENOME SCI INC: "Human secreted protein sequence #39", XP002193348 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
EP1294884A2 (fr) 2003-03-26
AU2001273070A1 (en) 2002-01-14
CA2410679A1 (fr) 2002-01-10
JP2004528002A (ja) 2004-09-16
WO2002002610A2 (fr) 2002-01-10

Similar Documents

Publication Publication Date Title
WO2000070049A3 (fr) Molecules de signalisation extracellulaires
WO2001012662A3 (fr) Proteines associees a la membrane
WO2002046383A3 (fr) Molecules de modification et de maintenance proteiques
WO2002063005A3 (fr) Molecules associees a des lipides
WO2002038602A3 (fr) Proteines secretees
WO2001098353A3 (fr) Proteines secretees
WO2001098354A3 (fr) Recepteurs
WO2002048337A3 (fr) Proteines secretees
WO2001072777A3 (fr) Facteurs de transcription
WO2001079291A3 (fr) Proteines secretees
WO2002026950A3 (fr) Transferases
WO2002034783A3 (fr) Proteines transmembranaires
WO2001032888A3 (fr) Molecules humaines de la transferase
WO2001096546A3 (fr) Proteine-phosphatases
WO2001085942A3 (fr) Proteines associees au cytosquelette
WO2002010363A3 (fr) Proteines phosphatases
WO1999041373A3 (fr) Molecules humaines associees au transport
WO2002002610A3 (fr) Molecules de circulation et de secretion
WO2000065054A3 (fr) Proteines humaines associees aux membranes
WO2002026982A3 (fr) Proteines secretees
WO2002024924A3 (fr) Proteine phosphatases
WO2002066646A3 (fr) Proteines associees a la neurotransmission
WO2001092527A3 (fr) Regulateurs de l'apoptose
WO2002026998A3 (fr) Hydrolases
WO2001051636A3 (fr) Proteines secretees

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2410679

Country of ref document: CA

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 507862

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2001952303

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001952303

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10311626

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001952303

Country of ref document: EP